These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 37748492)

  • 21. Circulating tumor cell-derived organoids: Current challenges and promises in medical research and precision medicine.
    Praharaj PP; Bhutia SK; Nagrath S; Bitting RL; Deep G
    Biochim Biophys Acta Rev Cancer; 2018 Apr; 1869(2):117-127. PubMed ID: 29360544
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Precision Oncology: Are We There Yet?
    EBioMedicine; 2017 Apr; 18():1-2. PubMed ID: 28442127
    [No Abstract]   [Full Text] [Related]  

  • 23. [Application of Organoids in Lung Cancer Precision Medicine].
    Jia Z; Liang N; Li S
    Zhongguo Fei Ai Za Zhi; 2020 Jul; 23(7):615-620. PubMed ID: 32702796
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Functional Optical Imaging of Primary Human Tumor Organoids: Development of a Personalized Drug Screen.
    Walsh AJ; Cook RS; Skala MC
    J Nucl Med; 2017 Sep; 58(9):1367-1372. PubMed ID: 28588148
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Precision medicine in pediatric oncology.
    Forrest SJ; Geoerger B; Janeway KA
    Curr Opin Pediatr; 2018 Feb; 30(1):17-24. PubMed ID: 29189430
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Precision medicine-based drug treatment individualization in oncology.
    Martin JH; Olver I
    Br J Clin Pharmacol; 2021 Feb; 87(2):223-226. PubMed ID: 33314335
    [No Abstract]   [Full Text] [Related]  

  • 27. Organoid technology in cancer precision medicine.
    Xia X; Li F; He J; Aji R; Gao D
    Cancer Lett; 2019 Aug; 457():20-27. PubMed ID: 31078736
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Giving Up on Precision Oncology? Not So Fast!
    Warner JL
    Clin Transl Sci; 2017 May; 10(3):128-129. PubMed ID: 28146309
    [No Abstract]   [Full Text] [Related]  

  • 29. The value of companion diagnostics in oncology drug development.
    Conn CW; Jin J
    Expert Rev Mol Diagn; 2022 Jun; 22(6):591-593. PubMed ID: 35815729
    [No Abstract]   [Full Text] [Related]  

  • 30. Think Globally, Act Locally: Globalizing Precision Oncology.
    Moyers JT; Subbiah V
    Cancer Discov; 2022 Apr; 12(4):886-888. PubMed ID: 35373284
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Precision Medicine in Oncology Pharmacy Practice.
    Saadeh C; Bright D; Rustem D
    Acta Med Acad; 2019 Apr; 48(1):90-104. PubMed ID: 31264437
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Next-Generation Sequencing in Oncology in the Era of Precision Medicine.
    Blumenthal GM; Mansfield E; Pazdur R
    JAMA Oncol; 2016 Jan; 2(1):13-4. PubMed ID: 26540172
    [No Abstract]   [Full Text] [Related]  

  • 33. Ethical considerations of neuro-oncology trial design in the era of precision medicine.
    Gupta S; Smith TR; Broekman ML
    J Neurooncol; 2017 Aug; 134(1):1-7. PubMed ID: 28555425
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Wargaming cancer: a strategy for future precision oncology?
    Ingesson T; Gisselsson D
    Trends Cancer; 2023 Sep; 9(9):697-699. PubMed ID: 37400316
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Personalized medicine in oncology: next generation.
    Chiang A; Million RP
    Nat Rev Drug Discov; 2011 Dec; 10(12):895-6. PubMed ID: 22129983
    [No Abstract]   [Full Text] [Related]  

  • 36. What role could organoids play in the personalization of cancer treatment?
    Francies HE; Garnett MJ
    Pharmacogenomics; 2015; 16(14):1523-6. PubMed ID: 26485224
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Patient-Derived Organoids for Precision Cancer Immunotherapy.
    Grönholm M; Feodoroff M; Antignani G; Martins B; Hamdan F; Cerullo V
    Cancer Res; 2021 Jun; 81(12):3149-3155. PubMed ID: 33687948
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Moving toward precision oncology centers V2.0.
    Dogan S; Cournède PH; Solary E; Heard JM; Aldea M; Conroy T; Robert C; André F
    Ann Oncol; 2023 Dec; 34(12):1088-1089. PubMed ID: 37805130
    [No Abstract]   [Full Text] [Related]  

  • 39. National Center for Tumor Diseases Precision Oncology Thesaurus for Drugs: A Curated Database for Drugs, Drug Classes, and Drug Targets in Precision Cancer Medicine.
    Kreutzfeldt S; Horak P; Hübschmann D; Knurr A; Fröhling S
    JCO Clin Cancer Inform; 2023 Mar; 7():e2200147. PubMed ID: 36888935
    [No Abstract]   [Full Text] [Related]  

  • 40. Evolution of precision oncology-guided treatment paradigms.
    DasGupta R; Yap A; Yaqing EY; Chia S
    WIREs Mech Dis; 2023 Jan; 15(1):e1585. PubMed ID: 36168283
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.